ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $47,000 | -54.4% | 32,085 | -55.6% | 0.00% | – |
| Q4 2016 | $103,000 | +87.3% | 72,238 | +133.8% | 0.00% | – |
| Q3 2016 | $55,000 | +2650.0% | 30,893 | +3359.5% | 0.00% | – |
| Q2 2016 | $2,000 | -96.7% | 893 | -97.1% | 0.00% | – |
| Q1 2016 | $61,000 | +7.0% | 30,893 | +2.7% | 0.00% | – |
| Q4 2015 | $57,000 | -16.2% | 30,073 | -16.5% | 0.00% | – |
| Q3 2015 | $68,000 | -64.2% | 35,998 | -12.4% | 0.00% | – |
| Q2 2015 | $190,000 | +7.3% | 41,096 | +1.3% | 0.00% | – |
| Q1 2015 | $177,000 | +22.9% | 40,586 | -2.4% | 0.00% | – |
| Q4 2014 | $144,000 | +6.7% | 41,592 | +28.9% | 0.00% | – |
| Q3 2014 | $135,000 | -28.6% | 32,256 | -0.1% | 0.00% | – |
| Q2 2014 | $189,000 | -6.9% | 32,276 | +0.0% | 0.00% | – |
| Q1 2014 | $203,000 | -42.2% | 32,275 | -46.2% | 0.00% | -100.0% |
| Q4 2013 | $351,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 9,750,000 | $18,623,000 | 1.60% |
| DAFNA Capital Management LLC | 381,600 | $729,000 | 0.72% |
| SENZAR ASSET MANAGEMENT, LLC | 1,766,991 | $3,374,953,000 | 0.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,640,877 | $8,864,000 | 0.34% |
| Lyons Wealth Management, LLC. | 56,665 | $110,000 | 0.14% |
| FEDERATED HERMES, INC. | 5,648,920 | $10,789,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 33,909,459 | $64,767,000 | 0.02% |
| Cubist Systematic Strategies, LLC | 185,166 | $354,000 | 0.02% |
| GAM Holding AG | 523,164 | $997,000 | 0.02% |
| STEVENS CAPITAL MANAGEMENT LP | 191,236 | $365,000 | 0.02% |